Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-016719
Filing Date
2011-03-09
Accepted
2011-03-09 12:13:29
Documents
1
Period of Report
2011-03-07

Document Format Files

Seq Description Document Type Size
1 VESTED RSU RELEASE rrd304567.html 4  
1 VESTED RSU RELEASE rrd304567.xml 4 5209
  Complete submission text file 0001181431-11-016719.txt   6791
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Nicholson John (Reporting) CIK: 0001420766 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 11674265